본문 바로가기
KERD
논문KCI 등재

The application of new breeding technology based on gene editing in pig industry - A review

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Genome/gene-editing (GE) techniques, characterized by a low technological barrier, high efficiency, and broad application among organisms, are now being employed not only in medical science but also in agriculture/veterinary science. Different engineered CRISPR/Cas9s have been identified to expand the application of this technology. In pig production, GE is a precise new breeding technology (NBT), and promising outcomes in improving economic traits, such as growth, lean or healthy meat production, animal welfare, and disease resistance, have already been documented and reviewed. These promising achievements in porcine gene editing, including the Myostatin gene knockout (KO) in indigenous breeds to improve lean meat production, the uncoupling protein 1 (UCP1) gene knock-in to enhance piglet thermogenesis and survival under cold stress, the generation of GGTA1 and CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene double KO (dKO) pigs to produce healthy red meat, and the KO or deletion of exon 7 of the CD163 gene to confer resistance to porcine reproductive and respiratory syndrome virus infection, are described in the present article. Other related approaches for such purposes are also discussed. The current trend of global regulations or legislation for GE organisms is that they are exempted from classification as genetically modified organisms (GMOs) if no exogenes are integrated into the genome, according to product-based and not process-based methods. Moreover, an updated case study in the EU showed that current GMO legislation is not fit for purpose in term of NBTs, which contribute to the objectives of the EU's Green Deal and biodiversity strategies and even meet the United Nations' sustainable development goals for a more resilient and sustainable agri-food system. The GE pigs generated via NBT will be exempted from classification as GMOs, and their global valorization and commercialization can be foreseen.

Abstract

Genome/gene-editing (GE) techniques, characterized by a low technological barrier, high efficiency, and broad application among organisms, are now being employed not only in medical science but also in agriculture/veterinary science. Different engineered CRISPR/Cas9s have been identified to expand the application of this technology. In pig production, GE is a precise new breeding technology (NBT), and promising outcomes in improving economic traits, such as growth, lean or healthy meat production, animal welfare, and disease resistance, have already been documented and reviewed. These promising achievements in porcine gene editing, including the Myostatin gene knockout (KO) in indigenous breeds to improve lean meat production, the uncoupling protein 1 (UCP1) gene knock-in to enhance piglet thermogenesis and survival under cold stress, the generation of GGTA1 and CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene double KO (dKO) pigs to produce healthy red meat, and the KO or deletion of exon 7 of the CD163 gene to confer resistance to porcine reproductive and respiratory syndrome virus infection, are described in the present article. Other related approaches for such purposes are also discussed. The current trend of global regulations or legislation for GE organisms is that they are exempted from classification as genetically modified organisms (GMOs) if no exogenes are integrated into the genome, according to product-based and not process-based methods. Moreover, an updated case study in the EU showed that current GMO legislation is not fit for purpose in term of NBTs, which contribute to the objectives of the EU's Green Deal and biodiversity strategies and even meet the United Nations' sustainable development goals for a more resilient and sustainable agri-food system. The GE pigs generated via NBT will be exempted from classification as GMOs, and their global valorization and commercialization can be foreseen.

참고문헌 (100)

  1. Craft WA, "Fifty years of progress in swine breeding", J Anim Sci, 17, pp.960~980 (1958)[DOI]
  2. Knap PW, "Resource allocation theory applied to farm animal production", pp.210~229 (2009), CABI International
  3. Yang TS, "Advances in zoology research", pp.187~200 (2012), Nova Science Publishers, Inc.
  4. Merks JWM, "New phenotypes for new breeding goals in pigs", Animal, 6(4), pp.535~543 (2012)[DOI]
  5. Hermesch S, "Selection for productivity and robustness traits in pigs", Anim Prod Sci, 55, pp.1437~1447 (2015)[DOI]
  6. Ryu J, "Use of gene-editing technology to introduce targeted modifications in pigs", J Anim Sci Biotechnol, 9, pp.5~ (2018)[DOI]
  7. Yang H, "Genome editing of pigs for agriculture and biomedicine", Front Genet, 9, pp.360~ (2018)[DOI]
  8. Zhao J, "Genome editing in large animals : current status and future prospects", Natl Sci Rev, 6, pp.402~420 (2019)[DOI]
  9. Penrith ML, "With or without a vaccine—A review of complementary and alternative approaches to managing african swine fever in resource-constrained smallholder settings", Vaccines, 9, pp.116~ (2021)[DOI]
  10. Hansen PJ, "Prospects for gene introgression or gene editing as a strategy for reduction of the impact of heat stress on production and reproduction in cattle", Theriogenology, 154, pp.190~202 (2020)[DOI]
  11. Tanihara F, "Current status of the application of gene editing in pigs", J Reprod Dev, 67, pp.177~187 (2021)[DOI]
  12. Zhang J, "The advancements, challenges, and future implications of the CRISPR", Cas9system in swine research, 2021, pp.48, 347~360
  13. Petersen GEL, "Gene editing in Farm Animals : A Step Change for Eliminating Epidemics on our Doorstep", bioRxiv, ~ (2021)
  14. Moehle EA, "Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases", Proc Natl Acad Sci USA, 104, pp.3055~3060 (2007)[DOI]
  15. Christian M, "Targeting DNA doublestrand breaks with TAL effector nucleases", Genetics, 186, pp.757~761 (2010)[DOI]
  16. Cong L, "Multiplex genome engineering using CRISPR", Cas systems, 2013, pp.339, 819~823
  17. Stoddard BL, "Homing endonucleases : from microbial genetic invaders to reagents for targeted DNA modification", Structure, 19, pp.7~15 (2011)[DOI]
  18. Smith J, "Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains", Nucleic Acids Res, 28, pp.3361~3369 (2000)[DOI]
  19. Bibikova M, "Stimulation of homologous recombination through targeted cleavage by chimeric nucleases", Mol Cell Biol, 21, pp.289~297 (2001)[DOI]
  20. Streubel J, "TAL effector RVD specificities and efficiencies", Nat Biotechnol, 30, pp.593~595 (2012)[DOI]
  21. Richter A, "Methods in Molecular Biology, vol 1338", pp.9~25 (2016), Humana Press
  22. Cermak T, "Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA14 targeting", Nucleic Acids Res, 39, pp.e82~ (2011)[DOI]
  23. Cermak T, "Chromosomal mutagenesis. Methods in molecular biology (methods and protocols), vol 1239", pp.133~159 (2015), Humana Press
  24. Morbitzer R, "Assembly of custom TALE-type DNA binding domains by modular cloning", Nucleic Acids Res, 39, pp.5790~5799 (2011)[DOI]
  25. Zhang F, "Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription", Nat Biotechnol, 29, pp.149~153 (2011)[DOI]
  26. Deng P, "Viral vectors for gene therapy. Methods in molecular biology, vol 1937", pp.47~58 (2019), Humana Press
  27. Nitsch S, "Epigenome editing. Methods in molecular biology, vol 1767", pp.89~109 (2018), Humana Press
  28. Jinek M, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, 337, pp.816~821 (2012)[DOI]
  29. Josephs EA, "Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage", Nucleic Acids Res, 43, pp.8924~8941 (2015)[DOI]
  30. Sternberg SH, "Conformational control of DNA target cleavage by CRISPR-Cas9", Nature, 527, pp.110~113 (2015)[DOI]
  31. Lee K, "Current progress of genome editing in livestock", Theriogenology, 150, pp.229~235 (2020)[DOI]
  32. Nishimasu H, "Crystal structure of Cas9 in complex with guide RNA and target DNA", Cell, 156, pp.935~949 (2014)[DOI]
  33. Komor AC, "Programmable editing of a target base in genomic DNA without doublestranded DNA cleavage", Nature, 533, pp.420~424 (2016)[DOI]
  34. Gaudelli NM, "Programmable base editing of A. T to G. C in genomic DNA without DNA cleavage", Nature, 551, pp.464~471 (2017)[DOI]
  35. Richter MF, "Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity", Nat Biotechnol, 38, pp.883~891 (2020)[DOI]
  36. Komor AC, "Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C : G-to-T : A base editors with higher efficiency and product purity", Sci Adv, 3, pp.eaao4774~ (2017)[DOI]
  37. Anzalone AV, "Search-andreplace genome editing without double-strand breaks or donor DNA", Nature, 576, pp.149~157 (2019)[DOI]
  38. Marzec M, "Prime editing : a new way for genome editing", Trends Cell Biol, 30, pp.257~259 (2020)[DOI]
  39. Grobet L, "A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle", Nat Genet, 17, pp.71~74 (1997)[DOI]
  40. Grobet L, "Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle", Mamm Genome, 9, pp.210~213 (1998)[DOI]
  41. Czaja W, "Myostatin regulates pituitary development and hepatic IGF1", Am J Physiol Endocrinol Metab, 316, pp.E1036~E1049 (2019)[DOI]
  42. Qian L, "Targeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigs", Sci Rep, 5, pp.14435~ (2015)[DOI]
  43. Wang K, "Efficient generation of myostatin mutations in pigs using the CRISPR", Cas9 system, 2015, pp.5, 16623~
  44. Wang K, "Efficient generation of orthologous point mutations in pigs via CRISPR-assisted ssODNmediated homology-directed repair", Mol Ther Nucleic Acids, 5, pp.e396~ (2016)[DOI]
  45. Wang K, "CRISPR", Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs, 2017, pp.26, 799~805
  46. Zou YL, "Generation of pigs with a Belgian Blue mutation in MSTN using CRISPR", Cpf1-assisted ssODNmediated homologous recombination, 2019, pp.18, 1329~1336
  47. Paek HJ, "Association of myostatin deficiency with collagen related disease-umbilical hernia and tippy toe standing in pigs", Transgenic Res, 30, pp.663~674 (2021)[DOI]
  48. Xiang G, "Editing porcine IGF2 regulatory element improved meat production in Chinese Bama pigs", Cell Mol Life Sci, 75, pp.4619~4628 (2018)[DOI]
  49. Li R, "Precise editing of myostatin signal peptide by CRISPR", Cas9 increases the muscle mass of Liang Guang Small Spotted pigs, 2020, pp.29, 149~163
  50. Shi I, "The SCF-Fbxo40complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling", Dev Cell, 21, pp.835~847 (2011)[DOI]
  51. Zou Y, "An FBXO40 knockout generated by CRISPR", Cas9 causes muscle hypertrophy in pigs without detectable pathological effects, 2018, pp.498, 940~945
  52. Zhu X, "CRISPR", Cas9-mediated biallelic knockout of IRX3 reduces the production and survival of somatic cell-cloned Bama minipigs, 2020, pp.10, 501~
  53. Hou L, "Pig has no uncoupling protein 1", Biochem Biophys Res Commun, 487, pp.795~800 (2017)[DOI]
  54. Trayhurn P, "Evidence from immunoblotting studies on uncoupling protein that brown adipose tissue is not present in the domestic pig", Can J Physiol Pharmacol, 67, pp.1480~1485 (1989)[DOI]
  55. Berg F, "The uncoupling protein 1 gene (UCP1) is disrupted in the pig lineage: A genetic explanation for poor thermoregulation in piglets", PLoS Genet, 2, pp.e129~ (2006)[DOI]
  56. Lin J, "Cold adaptation in pigs depends on UCP3 in beige adipocytes", J Mol Cell Biol, 9, pp.364~375 (2017)[DOI]
  57. Zhang Q, "Reconstitution of UCP1 using CRISPR", Cas9 in the white adipose tissue of pigs decreases fat deposition and improves thermogenic capacity, 2017, pp.114, E9474~E9482
  58. Commins SP, "Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat", Allergol Int, 65, pp.16~20 (2016)[DOI]
  59. de la Fuente J, "Alpha-gal syndrome : challenges to understanding sensitization and clinical reactions to alpha-gal", Expert Rev Mol Diagn, 20, pp.905~911 (2020)[DOI]
  60. "FDA Approves first-of-its-kind intentional genomic alteration in line of domestic pigs for both human food, potential therapeutic uses" (2020)[URL]
  61. Jahan M, "The nonhuman glycan, N-glycolylneuraminic acid (Neu5Gc), is not expressed in all organs and skeletal muscles of nine animal species", Food Chem, 343, pp.128439~ (2021)[DOI]
  62. Tangvoranuntakul P, "Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid", Proc Natl Acad Sci USA, 100, pp.12045~12050 (2003)[DOI]
  63. Alisson-Silva F, "Human risk of diseases associated with red meat intake : Analysis of current theories and proposed role for metabolic incorporation of a nonhuman sialic acid", Mol Aspects Med, 51, pp.16~30 (2016)[DOI]
  64. Chuang Ck, "Generation of GGTA1mutant pigs by direct pronuclear microinjection of CRISPR", Cas9 plasmid vectors, 2017, pp.28, 174~181
  65. Tu CF, "Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR", Cas9 to nullify N-glycolylneuraminic acid expression, 2019, pp.14, e0217236~
  66. Yen CH, "Scaffold derived from GGTA1 and CMAH double knockout pigs elicits only slight inflammation in a gene-edited pig model", Materialia, 14, pp.100836~ (2020)[DOI]
  67. Ghosh D, "Advances in animal genomics", pp.75~89 (2021), Elsevier Inc
  68. You W, "CRISPR", Cas9-mediated specific integration of Fat-1 and IGF-1 at the pRosa26 locus, 2021, pp.12, 1027~
  69. Gu H, "Targeted overexpression of PPARγin skeletal muscle by random insertion and CRISPR", Cas9 transgenic pig cloning enhances oxidative fiber formation and intramuscular fat deposition, 2021, pp.35, e21308~
  70. Whitworth KM, "Use of the CRISPR", Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos, 2014, pp.91, 78~
  71. Burkard C, "Precision engineering for PRRSV resistance in pigs : Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function", PLoS Pathogens, 13, pp.e1006206~ (2017)[DOI]
  72. Yang H, "CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus", Antiviral Res, 151, pp.63~70 (2018)[DOI]
  73. Guo C, "Highly efficient generation of pigs harboring a partial deletion of the CD163 SRCR5 domain, which are fully resistant to porcine reproductive and respiratory syndrome virus 2 infection", Front Immunol, 10, pp.1846~ (2019)[DOI]
  74. Wang H, "Deletion of CD163 exon 7confers resistance to highly pathogenic porcine reproductive and respiratory viruses on pigs", Int J Biol Sci, 15, pp.1993~2005 (2019)[DOI]
  75. Xu K, "CD163 and pAPN double-knockout pigs are resistant to PRRSV and TGEV and exhibit decreased susceptibility to PDCoV while maintaining normal production performance", elife, 9, pp.e57132~ (2020)[DOI]
  76. Tanihara F, "Generation of CD163-edited pig via electroporation of the CRISPR", Cas9 system into porcine in vitro-fertilized zygotes, 2021, pp.32, 147~154
  77. Lillico SG, "Mammalian interspecies substitution of immune modulatory alleles by genome editing", Sci Rep, 6, pp.21645~ (2016)[DOI]
  78. Popescu L, "Genetically edited pigs lacking CD163 show no resistance following infection with the ASFV isolate, Georgia 2007-1", Virology, 501, pp.102~106 (2017)[DOI]
  79. Whitworth KM, "Resistance to coronavirus infection in amino peptidase N-deficient pigs", Transgenic Res, 28, pp.21~32 (2019)[DOI]
  80. Xie Z, "Genetically modified pigs are protected from classical swine fever virus", Plos Pathog, 14, pp.e1007193~ (2018)[DOI]
  81. Van Breedam W, "Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage", J Gen Virol, 91(Pt 7), pp.1659~1667 (2010)[DOI]
  82. Prather RS, "An intact sialoadhesin(Sn-SIGLEC1-CD169)is not required for attachment", internalization of the porcine reproductive and respiratory syndrome virus, 2013, pp.87, 9538~9546
  83. Zhang Q, "PRRS virus receptors and their role for pathogenesis", Vet Microbiol, 177, pp.229~241 (2015)[DOI]
  84. Whitworth KM, "Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus", Nat Biotechnol, 34, pp.20~22 (2016)[DOI]
  85. Burkard C, "Pigs lacking the scavenger receptor cysteine-rich domain 5 of CD163 are resistant to porcine reproductive and respiratory syndrome virus 1 infection", J Virol, 92, pp.e00415~e00418 (2018)[DOI]
  86. Whitworth KM, "Gene editing as applied to prevention of reproductive porcine reproductive and respiratory syndrome", Mol Reprod Dev, 84, pp.926~923 (2017)[DOI]
  87. Alcami A, "Interaction of African swine fever virus with macrophages", Virus Res, 17, pp.93~104 (1990)[DOI]
  88. Sanchez-Torres C, "Expression of porcine CD163 on monocytes", macrophages correlates with permissiveness to African swine fever infection, 2003, pp.148, 2307~2323
  89. Palgrave CJ, "Species-specific variation in RELA underlies differences in NF-kappaB activity : a potential role in African swine fever pathogenesis", J Virol, 85, pp.6008~6014 (2011)[DOI]
  90. Lillico SG, "Live pigs produced from genome edited zygotes", Sci Rep, 3, pp.2847~ (2013)[DOI]
  91. McCleary S, "Substitution of warthog NF-κB motifs into RELA of domestic pigs is not sufficient to confer resilience to African swine fever virus", Sci Rep, 10, pp.8951~ (2020)[DOI]
  92. Hübner A, "Efficient inhibition of African swine fever virus replication by CRISPR", Cas9 targeting of the viral p30 gene (CP204L), 2018, pp.8, 1449~
  93. Wang Q, "Emerging and reemerging coronaviruses in pigs", Curr Opin Virol, 34, pp.39~49 (2019)[DOI]
  94. Song D, "Porcine epidemic diarrhea : a review of current epidemiology and available vaccines", Clin Exp Vaccine Res, 4, pp.166~176 (2015)[DOI]
  95. Sun R, "Genetic variability and phylogeny of current Chinese Porcine epidemic diarrhea virus strains based on spike, ORF3, and membranegenes", Sci World J, 2014, pp.208439~ (2014)[DOI]
  96. Hu S, "Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection", eLife, 4, pp.e06951~ (2015)[DOI]
  97. Schmidt SM, "The evolving landscape around genome editing in agriculture : Many countries have exempted or move to exempt forms of genome editing from GMO regulation of crop plants", EMBO Rep, 21, pp.e50680~ (2020)[DOI]
  98. Entine J, "Regulatory approaches for genome edited agricultural plants in select countries and jurisdictions around the world", Transgenic Res, 30, pp.551~584 (2021)[DOI]
  99. Van Enennaam AL, "Genetic engineering of livestock : The opportunity cost of regulatory delay", Annu Rev Anim Biosci, 9, pp.453~478 (2021)[DOI]
  100. "New plant breeding techniques: EU Commission finds GMO legislation not fit for purpose" (2021)[URL]

관련 논문AI추천

이 간행물의 다른 논문 (13건)